Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT00321308. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Phase II Trial Of Pemetrexed With Or Without PF-3512676 For The Treatment Of Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer After Failure Of One Prior Chemotherapy Regimen For Advanced Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To assess the efficacy and safety of PF-3512676 administered in combination with pemetrexed for the treatment of patients with locally advanced or metastatic NSCLC who have failed one prior chemotherapy regimen
Study identification
- NCT ID
- NCT00321308
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 36 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2006 (Type not available)
- Primary completion
- Jan 2008 (Actual)
- Completion
- Jan 2008 (Actual)
- Last update posted
- Sep 28, 2009
2006 – 2008
United States locations
- U.S. sites
- 17
- U.S. states
- 7
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Litchfield Park | Arizona | 85340 | — |
| Pfizer Investigational Site | Sun City | Arizona | 85351 | — |
| Pfizer Investigational Site | Bentonville | Arkansas | 72712 | — |
| Pfizer Investigational Site | Fayetteville | Arkansas | 72703 | — |
| Pfizer Investigational Site | Hudson | Florida | 34667 | — |
| Pfizer Investigational Site | New Port Richey | Florida | 34655 | — |
| Pfizer Investigational Site | Mahwah | New Jersey | 07430 | — |
| Pfizer Investigational Site | Midland Park | New Jersey | 07432 | — |
| Pfizer Investigational Site | Paramus | New Jersey | 07652 | — |
| Pfizer Investigational Site | Westwood | New Jersey | 07675 | — |
| Pfizer Investigational Site | Oneida | New York | 13421 | — |
| Pfizer Investigational Site | Oswego | New York | 13126 | — |
| Pfizer Investigational Site | Syracuse | New York | 13210-2306 | — |
| Pfizer Investigational Site | Syracuse | New York | 13210 | — |
| Pfizer Investigational Site | Sylvania | Ohio | 43560 | — |
| Pfizer Investigational Site | Seattle | Washington | 89109 | — |
| Pfizer Investigational Site | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00321308, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 28, 2009 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00321308 live on ClinicalTrials.gov.